Skip to main content

Animations

MJFF Publications

1731 - 1740 of 9156 Results
Title
Year
  • Year
  • 2014
  • 2017
  • 2024
  • 2024
  • 2025
  • 2024
  • 2023
  • 2023
  • 2024
  • 2025
  • TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord
    2014
    Summary Details
    RESTRICTED
    Title: TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-014-1299-6
    Citation Count: 288
  • Summary Details
    OPEN
    Title: LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20170014
    Citation Count: 168
  • Summary Details
    OPEN
    Title: Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2023.1328269
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Fluorescence microscopy shadow imaging for neuroscience
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2024.1330100
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Late Breaking News
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.70263
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Concerns with the new biological research criteria for synucleinopathy
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00213-8
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Trajectories of depressive symptoms over 20 years and subsequent lower urinary tract symptoms and impact among women
    Journal Name: Menopause
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/gme.0000000000002193
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000556
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13729
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.